NEA Management Company, LLC
Q3 2025 13F Holdings
- Locationtimonium, MD
- Num holdings
29
- Value ($000)
$1,822,265
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001512848
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
RYTM RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $293.88 M | 16 % | 2,909,956 | ||
ACLX ARCELLX INC | COMMON STOCK | 03940C100 | $250.02 M | 14 % | 3,045,262 | ||
VRNA VERONA PHARMA PLC | SPONSERED ADS | 925050106 | $240.42 M | 13 % | 2,252,994 | ||
COUR COURSERA INC | COM | 22266M104 | $150.68 M | 8 % | 12,867,769 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | $120.98 M | 7 % | 13,222,228 | ||
CELC CELCUITY INC | COM | 15102K100 | $105.93 M | 6 % | 2,144,261 | ||
YB4P SAVARA INC | COM | 805111101 | $87.36 M | 5 % | 24,471,264 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $68.61 M | 4 % | 1,058,570 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | $63.25 M | 4 % | 3,614,486 | ||
ZENAS BIOPHARMA INC | COM | 98937L105 | $60.69 M | 3 % | 2,733,719 |
Rows Per Page
10
- 10
- 50
- 100